Stomach Cancer Awareness Month: Advancing Innovation in Gastric Oncology 🎗️🔬During Stomach Cancer Awareness Month (November), we join global healthcare leaders, researchers, and oncology advocates in driving awareness for gastric cancer—the fifth most commonly diagnosed cancer and a leading cause of cancer mortality worldwide.

World Stomach Cancer Awareness Month November- 2026 Stomach cancer begins in the cells lining the mucosal (innermost) layer of the stomach wall and spreads outward through its five tissue layers as it grows It typically develops from precancerous changes in the stomach lining that progress slowly over several years Stomach Cancer Types of Stomach Cancer Risk Factors H. pylori Infection Odds Ratio (OR): 3.0 – 6.0 1. Adenocarcinoma The most common form, arising from mucus-producing cells of the stomach lining 2. Gastrointestinal Stromal Tumor (GIST) A rare type (arising in specialized nerve-like cells (interstitial cells of Cajal) within the stomach wall Genetics & Family History Odds Ratio (OR): ~2.0 Global Prevalence Smoking & Tobacco Use Odds Ratio (OR): -1.3 Over 1M cases annually worldwide High Sodium & Processed Diet Odds Ratio (OR): ~1.2 6th most common cancer worldwide 5th most common cause of cancer deaths worldwide 15.7 - 36.9 5.8 ~ 6.9 2.4 ~ 5.6 6.9 ~ 9.4 9.4 ~ 15.7 SEER Stages Localized Regional Distant 5- Year Survival Rate: 37% The cancer has spread outside the stomach to nearby structures or lymph nodes 5- Year Survival Rate: 77% There is no sign that the cancer has spread outside of the stomach 5- Year Survival Rate: 8% The cancer has spread to distant parts of the body, such as the liver Note: These numbers are based on people who were diagnosed and treated at least 5 years earlier Diagnosis Current Treatment Category Tests / Procedures Endoscopy & Biopsy Upper Endoscopy Tissue Biopsy Biomarker & Molecular Testing HER2 Testing PD-L1 Expression MSI / dMMR Testing Imaging Tests Upper Gastrointestinal Series CT Scan Endoscopic Ultrasound (EUS) PET Scan MRI Surgery Endoscopic resection Subtotal gastrectomy Total gastrectomy Immunotherapy PD-1 Inhibitors Radiation Therapy Targeted Therapy HER2 protein VEGF receptor CLDN18.2 NTRK genes Chemotherapy Note: This report is generated based on publicly available data © Vyuhpharma®, All Rights Reserved

Connect with us

Please fill in the information below, and we'll get back to you.